EDITORIAL
Published on 07 Sep 2022
Editorial: The gut-kidney axis: A potential drug target for treating kidney diseases
doi 10.3389/fphar.2022.1012890
- 979 views
- 2 citations
- Frontiers in Pharmacology
- Renal Pharmacology
- Research Topics
- The Gut-Kidney Axis: A Potential Drug Target for Treating Kidney Diseases
The Gut-Kidney Axis: A Potential Drug Target for Treating Kidney Diseases
9,511
Total downloads
25k
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
ORIGINAL RESEARCH
Published on 15 Aug 2022
Pharmacological inhibition of SMYD2 protects against cisplatin-induced acute kidney injury in mice
doi 10.3389/fphar.2022.829630
- 3,099 views
- 8 citations
ORIGINAL RESEARCH
Published on 09 Jun 2022
Renoprotection of Microcystin-RR in Unilateral Ureteral Obstruction-Induced Renal Fibrosis: Targeting the PKM2-HIF-1α Pathway
doi 10.3389/fphar.2022.830312
- 2,835 views
- 7 citations
REVIEW
Published on 18 Mar 2022
The Intestinal Microbiota and Metabolites in the Gut-Kidney-Heart Axis of Chronic Kidney Disease
doi 10.3389/fphar.2022.837500
- 7,209 views
- 44 citations
ORIGINAL RESEARCH
Published on 24 Jan 2022
Understanding the Gut-Kidney Axis in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: An Analysis of Gut Microbiota Composition
doi 10.3389/fphar.2022.783679
- 2,016 views
- 14 citations
ORIGINAL RESEARCH
Published on 13 Dec 2021
Rhubarb Enema Decreases Circulating Trimethylamine N-Oxide Level and Improves Renal Fibrosis Accompanied With Gut Microbiota Change in Chronic Kidney Disease Rats
doi 10.3389/fphar.2021.780924
- 3,187 views
- 25 citations
Published in
Frontiers in Pharmacology
- Renal Pharmacology
Impact
- 25kTopic views
- 14kArticle views
- 9,511Article downloads